Unternehmen Orion Biotech Opportunities Corp. OTC Markets
Aktien
A3CPS3
KYG6780C1252
ORIAU
Holdinggesellschaften
Kurzporträt
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Zuie Chin Huang
FOU | Founder | 58 | 05.02.21 |
Chrystyna Stecyk
FOU | Founder | 61 | 05.02.21 |
Mark Kayal
DFI | Director of Finance/CFO | 39 | - |
Director/Board Member | 51 | - | |
Samuel Broder
BRD | Director/Board Member | 79 | - |
Corporate Officer/Principal | - | - | |
John Phelan
PRN | Corporate Officer/Principal | 60 | - |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Zuie Chin Huang
FOU | Founder | 58 | 05.02.21 |
Samuel Broder
BRD | Director/Board Member | 79 | - |
James Collins
BRD | Director/Board Member | 58 | - |
Director/Board Member | 51 | - | |
Louisa Rodriguez
BRD | Director/Board Member | 64 | - |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 5 000 000 | 0 | 0 | 74,00 % |
Aktie B | 1 | 20 000 000 | 18 500 000 ( 92,50 %) | 0 |
Unternehmenskontakt
Orion Biotech Opportunities Corp.
One Vanderbilt Avenue 26th floor
10017, New York
+
http://www.orionbiotechopportunities.comSektor
% 1. Jan. | Kap. | |
---|---|---|
+137.37% | 5.68 Mrd. | |
+1.89% | 1.01 Mrd. | |
+2.19% | 982 Mio. | |
+41.91% | 872 Mio. | |
+25.27% | 819 Mio. | |
+1.68% | 663 Mio. | |
+0.54% | 610 Mio. | |
-.--% | 600 Mio. | |
+21.31% | 552 Mio. |